Laurie Alsup

Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT.

Phytomedics, Inc. discovers, develops, and manufactures botanical therapeutics using proprietary platform technologies. The company was founded in December 1996 by Ilya Raskin and is headquartered in Jamesburg, NJ.

NDA Group AB provides drug developmental consultancy services to the pharmaceutical industry. It focuses on all phases of development and therapeutic areas such as pre-submission, submission, assessment, post authorization, regulatory, pharmacovigilance, and health technology assessment. The company was founded in 1997 and is headquartered in Upplands Väsby, Sweden.

PharmApprove LLC provides strategic regulatory and scientific communications consultancy services to the pharmaceutical and biotech industries. The firm offers both strategic and tactical support to companies facing high-profile, high stakes events and engagements anywhere along the road to approval and commercialization -including FDA Advisory Committee meetings. The company was founded by Pete Taft in 1999 and is headquartered in Lawrenceville, NJ.